Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study

Medication-overuse headache (MOH) represents a severely disabling condition, with a low response to prophylactic treatments. Recently, consistent evidences have emerged in favor of botulinum toxin type-A (onabotulinum toxin A) as prophylactic treatment in chronic migraine. In a 12-week double-blind,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandrini, Giorgio, Perrotta, Armando, Tassorelli, Cristina, Torelli, Paola, Brighina, Filippo, Sances, Grazia, Nappi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2011
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139089/
https://www.ncbi.nlm.nih.gov/pubmed/21499747
http://dx.doi.org/10.1007/s10194-011-0339-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139089/
https://www.ncbi.nlm.nih.gov/pubmed/21499747
http://dx.doi.org/10.1007/s10194-011-0339-z

Ejemplares similares